BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ZContent.net//ZapCalLib 1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
SUMMARY:Advancing SARS-CoV-2 Antibody Detection: Bridging Sensitivity and A
 ccessibility
LOCATION:Chemistry A101
TZID:America/Denver
DTSTART:20231025T160000
UID:2026-05-17-18-44-25@natsci.colostate.edu
DTSTAMP:20260517T184425
Description:Title: Advancing SARS-CoV-2 Antibody Detection: Bridging Sensit
 ivity and Accessibility\n\nAbstract: \n\nThe emergence of severe acute re
 spiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the need for
  affordable and rapid serological tests to improve diagnostic reliability 
 and assess immune status. Conventional laboratory techniques like the enzy
 me-linked immunosorbent assay (ELISA) and the plaque reduction neutralizat
 ion test (PRNT)\, while sensitive\, are costly\, time-consuming\, and requ
 ire trained personnel. In response\, the development of the lateral flow i
 mmunoassay (LFIA) offers a cost-effective\, user-friendly alternative\, pr
 oviding results in just 10-30 minutes. However\, this assay suffers from d
 ecreased sensitivity and selectivity\, and is not quantitative. Therefore\
 , there is still a significant knowledge gap that needs to be addressed to
  bridge the sensitivity of traditional methods with the accessibility of t
 he LFIA. 4:00 pm
END:VEVENT
END:VCALENDAR